[E-Daily Reporter Kim Hyung-il ] Laser healthcare specialist LAMEDITECH Co., Ltd.(462510)announced on the 11th that it has begun actively seeking local partners and negotiating export agreements to enter the Middle Eastern medical aesthetics market.

LAMEDITECH Co., Ltd. participated in “Dubai Derma 2026,” held at the Dubai World Trade Center in the United Arab Emirates (UAE) from the 8th to the 10th, and showcased the Puraxel MX—a professional-grade laser beauty device—and the Puraxel ME-in—a home-care beauty device— .

During the exhibition, clinics and medical device distributors from the Middle East, North Africa, and neighboring markets—including the UAE, Saudi Arabia, Kuwait, Egypt, Morocco, and Pakistan—visited the LAMEDITECH Co., Ltd. booth. Some partners made specific inquiries regarding product configurations, application methods, clinic implementation, and after-sales support systems.

LAMEDITECH Co., Ltd. is currently finalizing discussions with potential partners identified at the exhibition regarding product adoption terms, distribution strategies, and local support systems. The company has also received requests from buyers in some countries for multiple sample orders to conduct practical feasibility studies.

Buyers from Europe also expressed interest in home-care beauty devices—including the PuraCell Beauty—as well as cosmetics and Original Design Manufacturing (ODM) development. Based on this, LAMEDITECH Co., Ltd. confirmed the potential for global business expansion not only in professional medical aesthetic devices but also in home-care products and the ODM business.

LAMEDITECH Co., Ltd. plans to expand its export market in the Middle East and North Africa (MENA) region by establishing the United Arab Emirates as a strategic hub. Following the supply of samples, the company intends to pursue country-specific regulatory approvals, product training, technical support, and after-sales service to ensure that local evaluations translate into tangible business results.

LAMEDITECH Co., Ltd. representative stated, “At this exhibition, we went beyond simple product inquiries to engage in concrete discussions regarding adoption by local clinics and country-specific distribution, and we also received requests from some buyers for samples to assess market potential.” The representative added, “We will actively pursue country-specific regulatory approvals, product training, technical support, and after-sales service to ensure that local evaluations following the supply of samples lead to tangible business results, thereby expanding our sales channels in the Middle East and North Africa region.”